This is the third in a three-part series by Dr. Heather Buschman on Big Data in the pharmaceutical and biotechnology industries. Check out…
Read MoreThis is the second in a three-part series by Dr. Heather Buschman on Big Data in the pharmaceutical and biotechnology industries. Check out…
Read MoreLuke Timmerman recently posted a nice blog at Xconomy talking about the poor public perception of the pharmaceutical industry and what the industry…
Read MoreWith the Big Data Science Innovation Summit 1 happening next month here in San Diego, we invited Dr. Heather Buschman to share current views on Big…
Read MoreThe need for CNS therapeutics is on the rise. Neurological diseases are expected to increase steadily in the coming years. Previously, we addressed…
Read More